R130 / Yunying Medicine - LARVOL DELTA

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors (clinicaltrials.gov) - P1 | N=9 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

New P1 trial • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • IFNG • IL10 • IL2 • IL6 • TNFA

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

New P1 trial • Brain Cancer • Breast Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Kidney Cancer • Lung Cancer • Melanoma • Oncology • Renal Cell Carcinoma • Sarcoma • Solid Tumor • CXCL8 • IL10 • IL2 • IL4 • IL6

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

IO biomarker • Metastases • New P1 trial • Oncolytic virus • Breast Cancer • Colorectal Cancer • Gastric Cancer • Gastrointestinal Cancer • Head and Neck Cancer • Hepatology • Liver Cancer • Lung Cancer • Neuroendocrine Tumor • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Sarcoma • Small Cell Lung Cancer • Solid Tumor • CXCL8 • IL10 • IL2 • IL4 • IL6

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

IO biomarker • Metastases • New P1 trial • Oncolytic virus • Breast Cancer • Colorectal Cancer • Gastric Cancer • Gastrointestinal Cancer • Gynecologic Cancers • Hepatology • Liver Cancer • Lung Cancer • Oncology • Pancreatic Cancer • Sarcoma • Solid Tumor • CXCL8 • IL10 • IL2 • IL4 • IL6

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

New P1 trial • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • CXCL8 • IL10 • IL2 • IL4 • IL6

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer (clinicaltrials.gov) - P1 | N=9 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

IO biomarker • New P1 trial • Oncolytic virus • Esophageal Cancer • Gastrointestinal Cancer • Head and Neck Cancer • Laryngeal Cancer • Oncology • Solid Tumor • CXCL8 • IL10 • IL2 • IL4 • IL6

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Shanghai Yunying Medical Technology

IO biomarker • New P1 trial • Oncolytic virus • Cervical Cancer • Endometrial Cancer • Oncology • Solid Tumor